Section 3.2.S.2.4 is typically provided in the restricted part of the DMF. However, any data that is relevant to the drug product manufacturer should be disclosed in the open part (CTD).
Section 3.2.S.2.4 is typically provided in the restricted part of the DMF. However, any data that is relevant to the drug product manufacturer should be disclosed in the open part (CTD).<br>